Rhodes Pharmaceuticals L.P. and Rhodes Technologies, subsidiaries of Purdue Pharma L.P., today announced they have joined the Prescription Drug Safety Network (“the Network”) to support EVERFI in deploying school-based prevention education on prescription medications across the state of Rhode Island and participate in Network initiatives.
The Network is a nationwide coalition of public and private-sector organizations created by EVERFI, a leader in prevention education, to bring investment, human capital, best practices, and prevention technology to schools across the nation to help address opioid and prescription drug abuse with a critical focus on high-school level prevention education and at-risk communities. More than 30 partner organizations including health systems, pharmaceutical manufacturers, distributors, pharmacies, foundations, and state leaders, support the Network’s efforts to enable EVERFI’s education specialists to drive local uptake of the curriculum.
EVERFI’s innovative, evidence-based prevention education curriculum provides students with basic information about three classes of prescription medicines (opioids, stimulants, and central nervous system depressants), including proper use and disposal, as well as interactive scenarios that help guide individual choices on potential situations involving misuse. EVERFI courses are aligned with the Centers for Disease Control and Prevention’s National Health Education Standards and state academic standards.
“There are very few initiatives aimed at positively preventing prescription drug abuse before it occurs, despite the fact that this type of abuse and misuse has devastated many communities across the country,” said EVERFI President of Global Partnerships Jon Chapman. “As students grow older, their access to prescription drugs and opportunities for misuse or abuse grows too. With the misuse of prescription drugs being the highest among young people ages 18-25, reaching students early is now more important than ever.”
Over the past two years, with the support of all Network members, EVERFI has reached more than 300,000 students in 3,021 middle and high schools and 81 colleges and universities. As part of its first Prescription Drug Safety Impact Report, EVERFI reported an average knowledge gain of 48 percent in categories including identifying the signs of prescription drug misuse (including changes in eating or sleeping habits, changes to personality, distancing from friends, or spending time alone or with a new group of friends), increasing confidence in their ability to step in to help someone who is misusing prescription drugs, and understanding effective refusal skills including how to respond to someone that might be attempting to influence an individual’s decision.1
“Helping our youth understand how to make safe choices about prescription medication use is critically important to the health of our community,” said Vincent Mancinelli, president, Rhodes Pharmaceuticals. “We are proud to support EVERFI’s efforts nationwide and we’re committed to doing our part to help improve the health and wellbeing of students across our home state of Rhode Island.”
Purdue joined the Network in 2017 with an initial commitment to support EVERFI’s efforts to increase course accessibility and utilization in five areas: California (Sacramento and surrounding communities), Connecticut (New Haven and surrounding communities), Ohio (Columbus and surrounding communities), eastern Tennessee, and southern West Virginia. In 2018, Purdue expanded its commitment to include the entire state of Connecticut, home to its corporate headquarters, and announced a collaboration with the Connecticut Prevention Network. Beginning with the 2019-2020 academic year, Purdue expanded its sponsorship in Tennessee to ensure all students across the state have access to the Prescription Drug Safety course. Adlon Therapeutics L.P., a subsidiary of Purdue, also recently joined the Network and committed to provide support for EVERFI to deploy its course throughout most of North Carolina and all of South Carolina beginning with the 2019-2020 academic year.
EVERFI is a technology company driving social change through education that addresses the biggest issues affecting society ranging from financial wellness to prescription drug safety to workplace conduct. Founded in 2008, EVERFI is fueled by its Software-as-a-Service (SaaS) platform and has reached more than 30 million learners across the U.S. and Canada. EVERFI’s Networks bring together financial institutions, colleges and universities, and some of the largest corporations to leverage insights and connections to drive impact. Some of America’s leading CEOs and venture capital firms are EVERFI investors including Amazon founder and CEO Jeff Bezos, Google Chairman Eric Schmidt, Twitter founder Evan Williams, Advance Publications, Rethink Education and Rethink Impact. To learn more about EVERFI visit everfi.com or follow us on Facebook, Instagram, LinkedIn, or Twitter @EVERFI.
About Rhodes Pharmaceuticals L.P.
Rhodes Pharmaceuticals L.P. has developed and distributed quality pharmaceutical products nationwide since 2008. With our R&D capabilities, industry partnerships, broad customer base, and strong relationships with suppliers, we offer reliable supply of high-quality products at competitive prices. Rhodes is a wholly owned subsidiary of Purdue Pharma L.P. For more information about Rhodes Pharmaceuticals L.P. visit www.rhodespharma.com.
1 Prescription Drug Safety Network. Prescription Drug Safety Course. K-12 Impact Report 2018-2019. Retrieved from: https://everfi.com/networks/prescription-drug-safety-network/impact/.
Accessed October 21, 2019.